1. Beclomethasone dipropionate in microscopic colitis: Results of an exploratory open‐label multicentre study (COLCO). Issue 9 (1st November 2019) Authors: De Corte, Thomas; Janssens, Emilie; D'Hondt, Ann; Thorrez, Koen; Arts, Joris; Dejaegher, Katrien; D'Heygere, François; Holvoet, Annelies; van Besien, Bart; Harlet, Luc; Peeters, Harald; Van Moerkercke, Wouter; Baert, Filip Journal: United European Gastroenterology journal Issue: Volume 7:Issue 9(2019) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response. Issue 2 (28th February 2021) Authors: Outtier, An; Wauters, Lucas; Rahier, Jean‐Francois; Bossuyt, Peter; Colard, Arnaud; Franchimont, Denis; Lambrecht, Guy; Macken, Elisabeth; Van Moerkercke, Wouter; Baert, Filip; Humblet, Evelien; Van Hootegem, Philippe; Gils, Ann; Ferrante, Marc; Vermeire, Séverine Journal: GastroHep Issue: Volume 3:Issue 2(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases. Issue 6 (July 2019) Authors: Liefferinckx, Claire; Verstockt, Bram; Gils, Ann; Tops, Sophie; Van Moerkercke, Wouter; Vermeire, Severine; Franchimont, Denis Journal: United European Gastroenterology journal Issue: Volume 7:Issue 6(2019) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of first‐line infliximab on the pharmacokinetics of second‐line vedolizumab in inflammatory bowel diseases. Issue 6 (1st July 2019) Authors: Liefferinckx, Claire; Verstockt, Bram; Gils, Ann; Tops, Sophie; Van Moerkercke, Wouter; Vermeire, Severine; Franchimont, Denis Journal: United European Gastroenterology journal Issue: Volume 7:Issue 6(2019) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Issue 5 (13th April 2018) Authors: Van de Vondel, Saartje; Baert, Filip; Reenaers, Christine; Vanden Branden, Stijn; Amininejad, Leila; Dewint, Pieter; Van Moerkercke, Wouter; Rahier, Jean-François; Hindryckx, Pieter; Bossuyt, Peter; Ferrante, Marc Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 5(2018) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Issue 5 (23rd April 2018) Authors: Van de Vondel, Saartje; Baert, Filip; Reenaers, Christine; Vanden Branden, Stijn; Amininejad, Leila; Dewint, Pieter; Van Moerkercke, Wouter; Rahier, Jean-François; Hindryckx, Pieter; Bossuyt, Peter; Ferrante, Marc; Baert, F; De Wulf, D; Moortgat, L; De Cock, E; Decaestecker, L; D'Hondt, A; Van Mo... Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study. (16th April 2019) Authors: Liefferinckx, Claire; Verstockt, Bram; Gils, Ann; Noman, Maja; Van Kemseke, Catherine; Macken, Elisabeth; De Vos, Martine; Van Moerkercke, Wouter; Rahier, Jean-Francois; Bossuyt, Peter; Dutré, Joris; Humblet, Evelien; Staessen, Dirk; Peeters, Harald; Van Hootegem, Philippe; Louis, Edouard; Franch... Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 11(2019) Page Start: 1401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. (3rd October 2018) Authors: Moens, Annick; van Hoeve, Karen; Humblet, Evelien; Rahier, Jean-François; Bossuyt, Peter; Dewit, Sophie; Franchimont, Denis; Macken, Elisabeth; Nijs, Jochen; Posen, Annelies; Strubbe, Beatrijs; Van Hootegem, Anneleen; Van Moerkercke, Wouter; Vermeire, Séverine; Ferrante, Marc Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 1(2019) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study. Issue 1 (6th November 2019) Authors: Moens, Annick; van der Woude, C. Janneke; Julsgaard, Mette; Humblet, Evelien; Sheridan, Juliette; Baumgart, Daniel C.; Gilletta De Saint‐Joseph, Cyrielle; Nancey, Stéphane; Rahier, Jean‐François; Bossuyt, Peter; Cremer, Anneline; Dewit, Sophie; Eriksson, Carl; Hoentjen, Frank; Krause, Thomas; Lou... Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 1(2020) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Role of integrin expression in the prediction of response to vedolizumab: A prospective real‐life multicentre cohort study. Issue 4 (5th April 2022) Authors: De Galan, Cara; Gonzales, Gerard Bryan; Van Welden, Sophie; Tavernier, Simon Jan; Lobaton, Triana; Van Moerkercke, Wouter; Strubbe, Beatrijs; Peeters, Harald; Macken, Elisabeth; De Vos, Martine; Laukens, Debby; Hindryckx, Pieter Journal: Clinical and translational medicine Issue: Volume 12:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗